Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

NCT05640037 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT05640037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05640037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Completed
Start date
March 23, 2022
Completion date
March 20, 2024
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis